(Q51971292)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11125857%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

The effect of clozapine on the speed and accuracy of information processing in schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11125857%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

main subject

schizophrenia

0 references

information processing

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11125857%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

C A Galletly

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11125857%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C R Clark

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11125857%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A C McFarlane

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11125857%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11125857%20AND%20SRC:MED&resulttype=core&format=json

Progress in Neuro-Psychopharmacology & Biological Psychiatry

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11125857%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11125857%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11125857%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1329-1338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11125857%20AND%20SRC:MED&resulttype=core&format=json

National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

Attention and clinical symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

Effect of typical antipsychotic medications and clozapine on smooth pursuit performance in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

Subjective muscle weakness and hypotonia during clozapine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

Learning and memory impairment with benzhexol

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

Relationships between changes in symptom ratings, neurophysiological test performance and quality of life in schizophrenic patients treated with clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

Cognitive deficits and the neurobiology of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

Should schizophrenia be treated as a neurocognitive disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine: results from a double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

Effect of clozapine on motor function in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

Psychomotility in the functional psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900136-6

7 January 2021

10.1016/S0278-5846(00)00136-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11125857%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference